ST-elevation myocardial infarction: from “acute myocardial infarction network” to shock-centers
Authors:
Company:
1 A.I. Yevdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of the Russian Federation, Moscow, Russian Federation
2 Davydovskiy City Clinical Hospital of Moscow Department of Health, Moscow, Russian Federation
For correspondence: Sign in or register.
Type: Editorial article
DOI:
For citation: Shpektor A.V., Vasilieva E.Yu. ST-elevation myocardial infarction: from “acute myocardial infarction network” to shock-centers. Creative Cardiology. 2021; 15 (4): 435–9 (in Russ.). DOI: 10.24022/1997-3187-2021-15-4-435-439
Received / Accepted: 06.12.2021 / 08.12.2021
Keywords: “acute myocardial infarction network” shock centers, percutaneous coronary intervent
Abstract
The creation of “acute myocardial infarction (AMI) network” allowed the primary percutaneous coronary intervention in Moscow to become the main method of AMI treatment and to achieve a significant reduction in mortality. A further decrease in mortality may be associated, first of all, with more effective treatment of cardiogenic shock. Now is the time to create specialized shock centers within the “AMI network” that will have all the capabilities to use high-tech treatment methods within the framework of a multidisciplinary approach.References
- Zeymer U., Ludman P., Danchin N., Kala P., Laroche C., Sadeghi M. et al. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC EAPCI EORP STEMI Registry of the European Society of Cardiology. Eur. Heart J. 2021; 42 (44): 4536–49. DOI: 10.1093/eurheartj/ehab342
- Henry T.D., Tomey M.I., Tamis-Holland J.E., Thiele H., Rao S.V., Menon V. et al. Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2021; 143 (15): e815–29. DOI: 10.1161/CIR.0000000000000959
- Thiele H., Ohman E.M., Waha-Thiele S., Zeymer U., Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur. Heart J. 2019; 40 (32): 2671–83. DOI: 10.1093/eurheartj/ehz363
- Webb J.G., Sanborn T.A., Sleeper L.A., Carere R.G., Buller Ch.E., Slater J.N. et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am. Heart J. 2001; 141 (6): 964–70. DOI: 10.1067/mhj.2001.115294
- Thiele H., Akin I., Sandri M., Fuernau G., de Waha S., Meyer-Saraei R. et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N. Engl. J. Med. 2017; 377 (25): 2419–32. DOI: 10.1056/NEJMoa1710261
- Thiele H., Zeymer U., Neumann F.-J., Ferenc M., Olbrich H.-G., Hausleiter J. et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 2012; 367 (14): 1287–96. DOI: 10.1056/NEJMoa1208410
- Tehrani B.N., Truesdell A.G., Sherwood M.W. et al. Standardized team-based care for cardiogenic shock. J. Am. Coll. Cardiol. 2019; 73 (13): 1659–69. DOI: 10.1016/j.jacc.2018.12.084
- Van Diepen S., Katz J.N., Albert N.M., Henry T.D., Jacobs A.K., Kapur N.K. et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017; 136 (16): e232–68. DOI: 10.1161/CIR.0000000000000525
